Clinical trial
System for High Intensity EvaLuation During Radiation Therapy (SHIELD-RT): A Prospective Randomized Study of Machine Learning-directed Clinical Evaluations During Outpatient Cancer Radiation and Chemoradiation
NCT04277650 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- System for High Intensity EvaLuation During Radiation Therapy (SHIELD-RT): A Prospective Randomized Study of Machine Learning-directed Clinical Evaluations During Outpatient Cancer Radiation and Chemoradiation
- Lead sponsor
- Duke University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 7, 2018
- Completion date
- June 30, 2019
- Enrollment
- 311 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chemotherapeutic toxicity, radiation therapy complication